FNDC5 and hepatocellular carcinoma: The ROC analysis shows that the area under the ROC curve (AUC) of serum irisin to distinguish HCC patients from healthy controls was 0.8364 (95% CI 0.7826-0.8902, P < 0.0001, Figure 2(b)).